Spyre Therapeutics to Participate in Upcoming November Investor Conferences

Rhea-AI Summary

Spyre Therapeutics (NASDAQ: SYRE) announced that management will participate in three investor conferences in November 2025: the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston on Nov 10, 2025 at 10:00 am ET, the Stifel 2025 Healthcare Conference in New York on Nov 11, 2025 at 8:40 am ET, and the Jefferies Global Healthcare Conference in London on Nov 19, 2025 at 8:00 am GMT. Live audio webcasts and replays will be available on the company’s investor events website at https://ir.spyre.com/events-and-presentations.

WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences:

Event: Guggenheim 2^nd Annual Healthcare Innovation Conference - Boston
Date: Monday, November 10, 2025
Fireside Time: 10:00 am ET

Event: Stifel 2025 Healthcare Conference – New York
Date: Tuesday, November 11, 2025
Fireside Time: 8:40 am ET

Event: Jefferies Global Healthcare Conference - London
Date: Wednesday, November 19, 2025
Fireside Time: 8:00 am GMT

Live audio webcasts and replays of these events will be available on the Spyre investor events website at https://ir.spyre.com/events-and-presentations.

About Spyre Therapeutics

Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases. Spyre's pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23.

For more information, visit Spyre's website at www.spyre.com.

For Investors:     
Eric McIntyre, Spyre Therapeutics
VP of Finance and Investor Relations
Eric.mcintyre@spyre.com 

FAQ

When will Spyre Therapeutics (SYRE) present at the Guggenheim Healthcare Innovation Conference?

Spyre will present on Monday, November 10, 2025 at 10:00 am ET.

How can investors listen to the Spyre (SYRE) presentations in November 2025?

Live audio webcasts and replays will be available at https://ir.spyre.com/events-and-presentations.

What time is Spyre Therapeutics (SYRE) scheduled to speak at the Stifel 2025 Healthcare Conference?

Spyre management is scheduled for Tuesday, November 11, 2025 at 8:40 am ET.

Does Spyre (SYRE) have a presentation at the Jefferies Global Healthcare Conference in London?

Yes. Spyre will participate on Wednesday, November 19, 2025 at 8:00 am GMT.

Will Spyre (SYRE) provide replays of its November 2025 investor event presentations?

Yes. Replays will be posted on the company’s investor events webpage at https://ir.spyre.com/events-and-presentations.